10x Genomics (TXG)

10x Genomics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as laboratory analytical instruments.

Download CSV

Short interest in 10x Genomics (TXG) was 12.5 million shares at the 30 October 2026 settlement, down 2.0% from the 15 October 2026 settlement, with days to cover at 4.1. In the last 90 days 10x Genomics insiders reported 25 open-market sales and no purchases, net sales of $12.6 million. The largest was a sale of 31,428 shares worth $2.0 million by Taich Adam (Chief Financial Officer) on 9 September 2026. The next earnings report for 10x Genomics is estimated for 11 February 2027.

12.5M

Short interest

settlement 2026-10-30

4.1

Days to cover

+1.5 days vs prior

43.0%

Short share of volume

2026-11-18

22

Fails to deliver

settlement 2026-10-26

Thu 11 Feb

Next earnings

estimated date

-$12.6M

Insider flow, 90 days

0 buys, 25 sells

As of 2026-11-18.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 October 2026, short interest in TXG is 12,473,112 shares, down 2,898,486 shares over the last month. Over the last 48 readings it ranged from 6,171,260 shares (13 December 2024) to 22,153,766 shares (15 May 2026). At the reported average volume of 3.0M shares a day that is 4.1 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/txg" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-3012,473,112-2.0%3,018,4004.13
2026-10-1512,732,231-17.2%4,796,6552.65
2026-09-3015,371,598-7.9%3,393,6584.53
2026-09-1516,692,300+3.3%2,354,3837.09
2026-08-3116,161,855+1.5%2,931,8135.51
2026-08-1415,927,548+1.9%3,483,7084.57
2026-07-3115,625,594-3.9%2,697,4435.79
2026-07-1516,252,519-0.5%3,043,0055.34
2026-06-3016,339,596-26.1%3,881,7034.21
2026-06-1522,103,160+34.0%3,264,0176.77
2026-05-2916,492,737-25.6%3,023,3905.46
2026-05-1522,153,766+36.4%2,792,0937.93
2026-04-3016,248,294-1.4%2,656,5256.12
2026-04-1516,474,248+2.8%2,307,3717.14
2026-03-3116,020,777+1.3%2,448,1826.54
2026-03-1315,810,579-3.6%1,950,5558.11
2026-02-2716,396,134-11.4%2,556,3656.41
2026-02-1318,515,015+13.5%3,079,0996.01
2026-01-3016,318,045-0.2%2,438,3686.69
2026-01-1516,344,883+7.8%2,873,3405.69
2025-12-3115,158,374-1.7%1,712,9858.85
2025-12-1515,420,723+4.2%2,149,3257.17
2025-11-2814,803,796-4.5%3,210,4204.61
2025-11-1415,501,651+3.2%3,696,1534.19
2025-10-3115,016,478+19.7%2,694,6715.57
2025-10-1512,546,318-0.2%2,417,8975.19
2025-09-3012,570,371-27.5%2,731,9744.60
2025-09-1517,346,695+26.3%2,333,7087.43
2025-08-2913,736,580+0.7%2,177,5046.31
2025-08-1513,643,549-5.6%3,644,2793.74
2025-07-3114,455,823+1.4%3,125,2664.63
2025-07-1514,263,062-3.7%3,069,5114.65
2025-06-3014,806,000+10.2%5,195,0122.85
2025-06-1313,434,164-16.1%4,283,0923.14
2025-05-3016,016,175+7.7%3,012,4945.32
2025-05-1514,876,610-4.0%4,142,0363.59
2025-04-3015,497,650+20.5%4,230,2523.66
2025-04-1512,860,779+6.7%3,552,3613.62
2025-03-3112,059,140-0.1%2,939,5184.10
2025-03-1412,075,180-12.3%3,419,6383.53
2025-02-2813,768,808+21.7%2,996,6434.59
2025-02-1411,315,858+34.3%3,563,6273.18
2025-01-318,423,614+10.8%1,917,2954.39
2025-01-157,605,935+15.2%1,947,6463.91
2024-12-316,600,347+7.0%1,605,3144.11
2024-12-136,171,260-10.6%1,617,3553.82
2024-11-296,904,875+0.7%2,241,5783.08
2024-11-156,858,911-9.8%2,167,4453.16

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 18 November 2026, the short share of TXG volume is 43.0%, down 5.2 points over the last five sessions. Over the last 30 readings it ranged from 18.6% (13 October 2026) to 71.1% (21 October 2026). The latest reading is in line with the 30-session average of 43.2%, on 555K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-18239K555K43.0%337
2026-11-17576K1.3M45.8%7,794
2026-11-16329K994K33.1%31
2026-11-13469K936K50.1%8,627
2026-11-12428K1.2M35.2%5,939
2026-11-11372K772K48.2%526
2026-11-10401K1.0M39.3%1,055
2026-11-09504K1.3M39.6%259
2026-11-06645K1.9M33.1%8,495
2026-11-05683K2.6M26.5%24,969
2026-11-04544K1.2M46.0%70
2026-11-03372K984K37.8%14,796
2026-11-02685K2.4M29.1%34,112
2026-10-301.0M2.1M48.3%37,344
2026-10-29501K750K66.8%137
2026-10-281.6M2.2M70.7%42
2026-10-27485K838K57.9%766
2026-10-26289K507K57.0%3,033
2026-10-23549K772K71.0%13,155
2026-10-22768K2.0M39.0%12,233
2026-10-211.0M1.5M71.1%8,874
2026-10-20453K1.3M35.6%929
2026-10-19402K1.1M37.7%904
2026-10-16540K1.5M35.9%1,096
2026-10-15596K2.0M30.4%6,993
2026-10-14730K1.6M46.0%70
2026-10-13347K1.9M18.6%25,614
2026-10-12629K1.9M33.3%19,701
2026-10-09819K1.8M45.8%375
2026-10-08721K3.0M24.4%1,843

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 26 October 2026, the fails-to-deliver balance in TXG is 22 shares, down 60 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (4 September 2026) to 185,128 shares (13 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-2622$71.55$2K
2026-10-1682$72.39$6K
2026-10-0965$77.28$5K
2026-10-08135$76.10$10K
2026-10-0790$80.66$7K
2026-09-2929$88.50$3K
2026-09-2819$85.71$2K
2026-09-214,538$76.60$348K
2026-09-171,100$72.68$80K
2026-09-11104,581$66.38$6.9M
2026-09-041$63.22$63
2026-08-3180$61.54$5K
2026-08-246,430$65.12$419K
2026-08-2119,127$63.87$1.2M
2026-08-19228$55.63$13K
2026-08-13185,128$57.75$10.7M
2026-08-127,033$58.48$411K
2026-08-111,575$58.57$92K
2026-08-064,296$47.46$204K
2026-07-294,276$47.05$201K
2026-07-275,569$46.27$258K
2026-07-2125$43.22$1K
2026-07-1723,533$44.48$1.0M
2026-07-16323$45.75$15K
2026-07-0137$38.34$1K
2026-06-3029,751$37.15$1.1M
2026-06-2472$31.87$2K
2026-06-222,282$34.76$79K
2026-06-127,078$29.05$206K
2026-06-0867$31.04$2K

Insider trades

SEC Form 4, newest first. JSON

Insiders at TXG reported 25 open-market sells worth $12.6M in the last 90 days and no open-market buys. Latest filing: Saxonov Serge (Chief Executive Officer) on 2026-11-10.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-11-10Saxonov SergeChief Executive OfficerSell31K$62.90$1.9M1.0M
2026-09-22SULIMAN SHEHNAAZDirectorSell1K$82.28$101K24K
2026-09-22SULIMAN SHEHNAAZDirectorSell2K$81.67$185K25K
2026-09-22SULIMAN SHEHNAAZDirectorSell1K$80.82$107K27K
2026-09-22SULIMAN SHEHNAAZDirectorSell614$79.51$49K29K
2026-09-22SULIMAN SHEHNAAZDirectorSell292$78.20$23K29K
2026-09-22Saxonov SergeChief Executive OfficerSell3K$82.36$231K1.1M
2026-09-22Saxonov SergeChief Executive OfficerSell10K$81.83$810K1.1M
2026-09-22Saxonov SergeChief Executive OfficerSell9K$80.90$752K1.1M
2026-09-22Saxonov SergeChief Executive OfficerSell2K$79.62$159K1.1M
2026-09-22Saxonov SergeChief Executive OfficerSell1K$78.23$78K1.1M
2026-09-09Taich AdamChief Financial OfficerSell14K$65.26$898K316K
2026-09-09Taich AdamChief Financial OfficerSell31K$64.31$2.0M330K
2026-09-09Taich AdamChief Financial OfficerSell1K$63.68$77K362K
2026-09-03STUELPNAGEL JOHN RDirectorSell6K$62.61$387K328K
2026-09-03STUELPNAGEL JOHN RDirectorSell7K$62.11$423K335K
2026-09-03STUELPNAGEL JOHN RDirectorSell7K$60.66$425K341K
2026-09-01Saxonov SergeChief Executive OfficerGift100$0.00$01.1M
2026-08-26Saxonov SergeChief Executive OfficerSell492$64.75$32K1.1M
2026-08-26Saxonov SergeChief Executive OfficerSell6K$63.98$415K1.1M
2026-08-26Saxonov SergeChief Executive OfficerSell4K$63.02$221K1.1M
2026-08-24Saxonov SergeChief Executive OfficerSell19K$63.02$1.2M1.1M
2026-08-24Taich AdamChief Financial OfficerSell17K$63.02$1.1M363K
2026-08-24Hindson Benjamin J.See RemarksSell14K$63.02$871K488K
2026-08-24SULIMAN SHEHNAAZDirectorSell2K$63.97$105K30K
2026-08-24SULIMAN SHEHNAAZDirectorSell561$62.73$35K31K
2026-08-20Saxonov SergeChief Executive OfficerGift4K$0.00$01.1M
2026-08-14Teichmann Sarah A.DirectorSell2K$57.15$130K28K
2026-08-13Teichmann Sarah A.DirectorSell5K$57.29$302K30K
2026-08-11STUELPNAGEL JOHN RDirectorSell3K$58.73$176K348K
2026-08-11STUELPNAGEL JOHN RDirectorSell17K$57.58$979K351K
2026-06-22Saxonov SergeChief Executive OfficerSell2K$36.16$60K1.1M
2026-06-22Saxonov SergeChief Executive OfficerSell10K$35.32$347K1.1M
2026-06-22Saxonov SergeChief Executive OfficerSell10K$34.28$343K1.1M
2026-06-22Saxonov SergeChief Executive OfficerSell9K$33.29$284K1.1M
2026-06-16SULIMAN SHEHNAAZDirectorSell364$33.27$12K32K
2026-06-16SULIMAN SHEHNAAZDirectorSell5K$32.59$175K32K
2026-06-04Teichmann Sarah A.DirectorGrant9K$0.00$036K
2026-06-04SULIMAN SHEHNAAZDirectorGrant9K$0.00$037K
2026-06-04STUELPNAGEL JOHN RDirectorGrant9K$0.00$0368K
2026-06-04Popovits Kimberly JDirectorGrant9K$0.00$037K
2026-06-04MATEO ALANDirectorGrant9K$0.00$086K
2026-06-04Kosaraju SridharDirectorGrant9K$0.00$065K
2026-05-26Saxonov SergeChief Executive OfficerSell11K$24.71$265K1.1M
2026-05-22Saxonov SergeChief Executive OfficerSell18K$24.44$444K1.1M
2026-05-22Hindson Benjamin J.See RemarksSell12K$24.44$283K502K
2026-05-22Taich AdamChief Financial OfficerSell15K$24.44$369K380K
2026-04-14Saxonov SergeChief Executive OfficerSell5K$24.56$123K1.2M
2026-03-24Saxonov SergeChief Executive OfficerSell5K$19.52$98K1.2M
2026-03-23Saxonov SergeChief Executive OfficerSell10K$19.13$191K1.2M
2026-03-03Saxonov SergeChief Executive OfficerGift3K$0.00$01.2M
2026-03-02Saxonov SergeChief Executive OfficerSell2K$23.18$43K1.2M
2026-03-02Saxonov SergeChief Executive OfficerSell14K$22.67$324K1.2M
2026-02-26Saxonov SergeChief Executive OfficerGrant158K$0.00$01.2M
2026-02-26Hindson Benjamin J.See RemarksGrant89K$0.00$0514K
2026-02-26Taich AdamChief Financial OfficerGrant107K$0.00$0395K
2026-02-25Teichmann Sarah A.DirectorSell8K$19.41$147K27K
2026-02-23Saxonov SergeChief Executive OfficerSell10K$18.58$179K1.1M
2026-02-23Taich AdamChief Financial OfficerSell9K$18.58$167K288K
2026-02-23Hindson Benjamin J.See RemarksSell8K$18.58$145K425K
2026-01-05Saxonov SergeChief Executive OfficerExercise or conversion50K$1.20$60K1.1M
2025-11-24Taich AdamChief Financial OfficerSell12K$19.00$226K297K
2025-11-24Hindson Benjamin J.See RemarksSell8K$19.00$157K433K
2025-11-24Saxonov SergeChief Executive OfficerSell13K$19.00$252K1.0M
2025-09-12Saxonov SergeChief Executive OfficerGift900$0.00$01.0M
2025-08-22Saxonov SergeChief Executive OfficerSell9K$13.79$129K946K
2025-08-22Taich AdamChief Financial OfficerSell22K$13.79$308K309K
2025-08-22Hindson Benjamin J.See RemarksSell7K$13.79$103K441K
2025-06-09Saxonov SergeChief Executive OfficerGift1K$0.00$0955K
2025-06-03Kosaraju SridharDirectorGrant15K$0.00$056K
2025-06-03MATEO ALANDirectorGrant15K$0.00$077K
2025-06-03Popovits Kimberly JDirectorGrant15K$0.00$029K
2025-06-03STUELPNAGEL JOHN RDirectorGrant15K$0.00$0360K
2025-06-03SULIMAN SHEHNAAZDirectorGrant15K$0.00$029K
2025-06-03Teichmann Sarah A.DirectorGrant15K$0.00$034K
2025-05-29Saxonov SergeChief Executive OfficerGift3K$0.00$01.1M
2025-05-22Taich AdamChief Financial OfficerSell4K$8.30$34K332K
2025-05-22Hindson Benjamin J.See RemarksSell7K$8.30$62K448K
2025-05-22Saxonov SergeChief Executive OfficerSell9K$8.30$78K1.1M
2025-03-17Taich AdamChief Financial OfficerGrant134K$0.00$0336K
2025-03-17Hindson Benjamin J.See RemarksGrant121K$0.00$0456K
2025-03-17Saxonov SergeChief Executive OfficerGrant171K$0.00$01.1M
2025-03-04Saxonov SergeChief Executive OfficerExercise or conversion50K$1.20$60K922K
2025-02-28Saxonov SergeChief Executive OfficerSell8K$10.63$84K872K
2025-02-24Saxonov SergeChief Executive OfficerSell5K$11.07$56K879K
2025-02-24Hindson Benjamin J.See RemarksSell5K$11.07$51K335K
2025-02-21MATEO ALANDirectorBuy40K$11.14$446K62K
2024-12-23Saxonov SergeChief Executive OfficerExercise or conversion12K$1.20$14K885K
2024-11-22Hindson Benjamin J.See RemarksSell6K$13.69$79K340K
2024-11-22Saxonov SergeChief Executive OfficerSell7K$13.69$92K873K
2024-11-21Saxonov SergeChief Executive OfficerGift2K$0.00$0879K
2024-11-14Saxonov SergeChief Executive OfficerGift1K$0.00$0881K
2024-10-23Taich AdamChief Financial OfficerGrant202K$0.00$0202K
2024-08-30Teichmann Sarah A.DirectorGrant19K$0.00$019K
2024-08-22McAnear Justin J.OtherSell3K$22.53$67K143K
2024-08-22Hindson Benjamin J.See RemarksSell4K$22.53$98K346K
2024-08-22Saxonov SergeChief Executive OfficerSell7K$22.53$152K882K
2024-07-31MATEO ALANDirectorGrant22K$0.00$022K
2024-06-11Mammen MathaiDirectorGrant9K$0.00$0180K
2024-06-11SULIMAN SHEHNAAZDirectorGrant9K$0.00$013K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

19 Form 144 notices on file for TXG worth $12.1M at the prices reported; 5 in the last 90 days worth $7.4M. Latest: ADAM TAICH filed on 2026-09-09 to sell 46,388 shares ($3.0M) from 2026-09-09.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-09-09ADAM TAICHOfficer46K$3.0M0.039%2026-09-09Morgan Stanley Smith Barney LLC Executive Financial Services
2026-09-03STUELPNAGEL JOHN RDirector20K$1.2M0.017%2026-09-03Wells Fargo Clearing Services
2026-08-24Taich AdamOfficer17K$1.1M0.014%2026-08-24Morgan Stanley Smith Barney LLC
2026-08-24Saxonov SergeOfficer, Director18K$1.2M0.015%2026-08-24Morgan Stanley Smith Barney LLC
2026-08-24Hindson Benjamin J.Officer, Director13K$871K0.011%2026-08-24Morgan Stanley Smith Barney LLC
2026-08-14SARAH A POLONIUS-TEICHMANNDirector2K$130K0.002%2026-08-14Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-13SARAH A POLONIUS-TEICHMANNDirector5K$302K0.004%2026-08-13Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-11STUELPNAGEL JOHN RDirector20K$1.2M0.017%2026-08-11Wells Fargo Clearing Services
2026-05-22Taich AdamOfficer12K$291K0.010%2026-05-22Morgan Stanley Smith Barney LLC Executive Services
2026-05-22Saxonov SergeOfficer, Director18K$443K0.015%2026-05-22Morgan Stanley Smith Barney LLC, Executive Services
2026-05-22Hindson Benjamin J.Officer, Director9K$233K0.008%2026-05-22Morgan Stanley Smith Barney LLC Executive Services
2026-03-02Serge SaxonovDirector, CEO41K$911K0.035%2026-03-02JP Morgan Securities LLC
2026-02-25SARAH A POLONIUS-TEICHMANNDirector8K$147K0.006%2026-02-25Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-23Taich AdamOfficer9K$176K0.008%2026-02-23Morgan Stanley Smith Barney LLC Executive Services
2026-02-23Saxonov SergeOfficer, Director10K$194K0.009%2026-02-23Morgan Stanley Smith Barney LLC Executive Services
2026-02-23Hindson Benjamin J.Officer, Director8K$159K0.007%2026-02-23Morgan Stanley Smith Barney LLC Executive Services
2025-11-24Taich AdamOfficer11K$207K0.010%2025-11-24Morgan Stanley Smith Barney LLC Executive Services
2025-11-24Saxonov SergeOfficer, Director13K$240K0.011%2025-11-24Morgan Stanley Smith Barney LLC Executive Services
2025-11-24Hindson Benjamin J.Officer, Director7K$136K0.006%2025-11-24Morgan Stanley Smith Barney LLC Executive Services

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

7 holders report 5% or more of TXG in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 15.6% of the class (18,543,562 shares), filed 2026-03-06 for an event on 2026-02-27.

FiledFormHolderSharesOf classEvent
2026-11-1613G/Ano. 1T. Rowe Price Associates, Inc.investment adviser17.5M14.5%2026-09-30
2026-10-0713G/Ano. 4Catherine D. Woodparent holding company, individual6.3M5.2%2026-09-30
2026-10-0713G/Ano. 4ARK Investment Management LLCinvestment adviser6.3M5.2%2026-09-30
2026-04-2913GVanguard Capital Managementinvestment adviser6.2M5.2%2026-03-31
2026-04-2813GVanguard Portfolio Managementinvestment adviser7.0M5.9%2026-03-31
2026-03-2513G/Ano. 7The Vanguard Groupinvestment adviser00.0%2026-03-13
2026-03-0613G/Ano. 14FMR LLCparent holding company18.5M15.6%2026-02-27
2026-03-0613G/Ano. 14Abigail P. Johnsonindividual18.5M15.6%2026-02-27
2025-11-1313G/Ano. 1Amova Asset Management Americas, Inc.investment adviser5.4M4.7%2025-09-30
2025-10-2713G/Ano. 1Sumitomo Mitsui Trust Group, Inc.parent holding company, non-US institution5.4M4.7%2025-09-30
2025-10-2713G/Ano. 1Amova Asset Management Co., Ltd.investment adviser, parent holding company, non-US institution5.4M4.7%2025-09-30

13F holders

Tracked managers holding TXG at their latest 13F. JSON

10 of the 30 tracked managers held TXG at their latest 13F, $864.4M in total at quarter-end prices. ARK Investment Management is the largest at $566.8M (3.3% of its portfolio) as of 2026-09-30. Over the prior quarter 3 added shares and 7 cut.

FundQuarterSharesValueOf portfolioChange in shares
ARK Investment Management2026-09-306.3M$566.8M3.26%-3.7M
AQR Capital Management2026-09-301.6M$147.7M0.04%-392K
Viking Global Investors2026-09-30747K$67.5M0.21%new
Millennium Management2026-09-30336K$30.3M0.01%+219K
D. E. Shaw & Co.2026-09-30182K$16.4M0.01%-51K
Two Sigma Investments2026-09-30121K$10.9M0.01%-21K
Bridgewater Associates2026-09-30116K$10.5M0.05%+103K
Point72 Asset Management2026-09-3075K$6.7M0.01%-1.8M
Renaissance Technologies2026-09-3066K$6.0M0.01%-736K
Citadel Advisors2026-09-3016K$1.4M0.00%-2.8M

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q3 FY 2026 (quarter ended 2026-09-30) 10x Genomics reported revenue of $150.7M, up 1.1% from the same quarter a year earlier, and net loss of $19.4M (-0.15 diluted EPS). In FY 2025 it generated $136.1M of operating cash flow.

Equity
$838.0M
Total assets
$1.06B

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q3 FY 20262026-09-30$150.7M-$19.4M-12.9%-0.15
Q2 FY 20262026-06-30$151.0M-$17.9M-11.9%-0.14
Q1 FY 20262026-03-31$150.8M-$13.5M-8.9%-0.10
Q4 FY 2025derived2025-12-31$166.0M-$16.3M-9.8%n/a
Q3 FY 20252025-09-30$149.0M-$27.5M-18.4%-0.22
Q2 FY 20252025-06-30$172.9M$34.5M20.0%0.28
Q1 FY 20252025-03-31$154.9M-$34.4M-22.2%-0.28
Q4 FY 2024derived2024-12-31$165.0M-$49.0M-29.7%n/a

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$642.8M-$43.5M$136.1M$5.9Mn/an/a
FY 20242024-12-31$610.8M-$182.6M$6.7M$12.4Mn/an/a
FY 20232023-12-31$618.7M-$255.1M-$15.2M$48.6Mn/an/a
FY 20222022-12-31$516.4M-$166.0M-$33.6M$131.7Mn/an/a
FY 20212021-12-31$490.5M-$58.2M-$21.4M$101.3Mn/an/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30.

What this page is

10x Genomics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows 10x Genomics (TXG), SEC CIK 1770787, listed on Nasdaq, classified by the SEC as laboratory analytical instruments. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-18.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-26.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-09.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-11-16.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-09-30.JSON and CSV
Financials
SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-11-05.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-11-10.JSON and CSV
Company record
EDGAR filing index for CIK 1770787Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of TXG is sold short?
12,473,112 shares were held short at the 2026-10-30 settlement, 4.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is TXG's daily short volume?
On 2026-11-18, 238,773 of the 555,107 TXG shares reported to FINRA were sold short, 43.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does TXG have fails to deliver?
The SEC's latest file shows 22 TXG shares failed to deliver at settlement 2026-10-26. Fails are reported per settlement date and published twice a month with a lag.
Are TXG insiders buying or selling?
Insiders at TXG reported 25 open-market sells worth $12.6M in the last 90 days and no open-market buys. Latest filing: Saxonov Serge (Chief Executive Officer) on 2026-11-10.
Have TXG insiders filed to sell?
19 Form 144 notices on file for TXG worth $12.1M at the prices reported; 5 in the last 90 days worth $7.4M. Latest: ADAM TAICH filed on 2026-09-09 to sell 46,388 shares ($3.0M) from 2026-09-09.
Who owns 5% or more of TXG?
7 holders report 5% or more of TXG in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 15.6% of the class (18,543,562 shares), filed 2026-03-06 for an event on 2026-02-27.
What did TXG report last quarter?
In Q3 FY 2026 (quarter ended 2026-09-30) 10x Genomics reported revenue of $150.7M, up 1.1% from the same quarter a year earlier, and net loss of $19.4M (-0.15 diluted EPS). In FY 2025 it generated $136.1M of operating cash flow.
Which tracked 13F managers own TXG?
10 of the 30 tracked 13F managers held TXG shares at their latest filing, $864.4M in all. The largest: Cathie Wood's ARK Investment Management (6.3M shares, $566.8M), Cliff Asness's AQR Capital Management (1.6M shares, $147.7M), Andreas Halvorsen's Viking Global Investors (747K shares, $67.5M), Izzy Englander's Millennium Management (336K shares, $30.3M), D. E. Shaw & Co. (182K shares, $16.4M), Two Sigma Investments (121K shares, $10.9M). The table above lists all 10.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.